Specialist Dr. Ender Kalaci

Specialist Dr. Ender Kalaci
Academic Title :
Specialist Dr.

Dr. Ender Kalaci is a Specialist Dr. in the Department of Medical Oncology at Liv Hospital Ankara, with extensive medical and clinical experience in diagnosing and treating various cancerous conditions and malignant tumors.

Education and Academic Qualifications

  • Medical Oncology Fellowship/Subspecialty Training, Department of Internal Medicine, Ankara University Faculty of Medicine, Turkey (2019-2023).
  • Internal Medicine Residency Training, Department of Internal Medicine, Ankara University Faculty of Medicine, Turkey (2014-2018).
  • Doctor of Medicine (MD), Akdeniz University Faculty of Medicine, Antalya, Turkey (2006-2012).

Areas of Interest

  • Personalized and Targeted Tumor Treatments
  • Molecular Oncology and Next-Generation Sequencing (NGS)
  • Kidney and Bladder Cancer
  • Lung Cancer
  • Stomach and Colorectal Cancers
  • Malignant Melanoma and Sarcomas
  • Specialist Dr. in Medical Oncology at Liv Hospital Ankara (2024-Present).
  • Medical Oncology Specialist at Bitlis Tatvan State Hospital, Turkey (State Service Obligation, 2023-2024).
  • Internal Medicine Specialist at Niğde Ömer Halisdemir Training and Research Hospital, Turkey (State Service Obligation, 2018-2019).
  • Turkish Medical Oncology Society (TTOD)
  • Ankara Medical Oncology Association (AMOD)
  • The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer, Tuberk Toraks, 2022.
  • Effects of Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia: A Retrospective Analysis, Leukemia Lymphoma Myeloma Research in Turkey, 2024.
  • Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study, Journal of Oncological Sciences, 2021.
  • Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia, Exp Clin Transplant, 2021.
  • Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study, Medicine (Baltimore), 2025.
Share :